ID   LIRA3_HUMAN             Reviewed;         439 AA.
AC   Q8N6C8; J3KPM2; O15469; O15470; O75016; Q8N151; Q8N154; Q8NHJ1; Q8NHJ2;
AC   Q8NHJ3; Q8NHJ4;
DT   03-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   04-APR-2006, sequence version 3.
DT   07-APR-2021, entry version 151.
DE   RecName: Full=Leukocyte immunoglobulin-like receptor subfamily A member 3;
DE   AltName: Full=CD85 antigen-like family member E;
DE   AltName: Full=Immunoglobulin-like transcript 6;
DE            Short=ILT-6;
DE   AltName: Full=Leukocyte immunoglobulin-like receptor 4;
DE            Short=LIR-4;
DE   AltName: Full=Monocyte inhibitory receptor HM43/HM31;
DE   AltName: CD_antigen=CD85e;
DE   Flags: Precursor;
GN   Name=LILRA3; Synonyms=ILT6, LIR4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT SER-3, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Lung, and Monocyte;
RX   PubMed=9278324;
RA   Arm J.P., Nwankwo C., Austen K.F.;
RT   "Molecular identification of a novel family of human Ig superfamily members
RT   that possess immunoreceptor tyrosine-based inhibition motifs and homology
RT   to the mouse gp49B1 inhibitory receptor.";
RL   J. Immunol. 159:2342-2349(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT SER-3, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=9548455;
RA   Borges L., Hsu M.-L., Fanger N., Kubin M., Cosman D.;
RT   "A family of human lymphoid and myeloid Ig-like receptors, some of which
RT   bind to MHC class I molecules.";
RL   J. Immunol. 159:5192-5196(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9079806; DOI=10.1002/eji.1830270313;
RA   Samaridis J., Colonna M.;
RT   "Cloning of novel immunoglobulin superfamily receptors expressed on human
RT   myeloid and lymphoid cells: structural evidence for new stimulatory and
RT   inhibitory pathways.";
RL   Eur. J. Immunol. 27:660-665(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-3.
RC   TISSUE=Peripheral blood leukocyte;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-420, AND VARIANTS ARG-107 AND
RP   HIS-301.
RX   PubMed=12750859; DOI=10.1007/s00251-003-0561-1;
RA   Norman P.J., Carey B.S., Stephens H.A., Vaughan R.W.;
RT   "DNA sequence variation and molecular genotyping of natural killer
RT   leukocyte immunoglobulin-like receptor, LILRA3.";
RL   Immunogenetics 55:165-171(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 24-38.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally verified
RT   cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [8]
RP   GLYCOSYLATION AT ASN-140; ASN-281; ASN-302; ASN-341 AND ASN-431, AND
RP   FUNCTION.
RX   PubMed=24085305; DOI=10.1074/jbc.m113.478578;
RA   Lee T.H., Mitchell A., Liu Lau S., An H., Rajeaskariah P., Wasinger V.,
RA   Raftery M., Bryant K., Tedla N.;
RT   "Glycosylation in a mammalian expression system is critical for the
RT   production of functionally active leukocyte immunoglobulin-like receptor A3
RT   protein.";
RL   J. Biol. Chem. 288:32873-32885(2013).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 24-120, DISULFIDE BOND, AND
RP   FUNCTION.
RX   PubMed=21559424; DOI=10.1371/journal.pone.0019245;
RA   Ryu M., Chen Y., Qi J., Liu J., Fan Z., Nam G., Shi Y., Cheng H., Gao G.F.;
RT   "LILRA3 binds both classical and non-classical HLA class I molecules but
RT   with reduced affinities compared to LILRB1/LILRB2: structural evidence.";
RL   PLoS ONE 6:E19245-E19245(2011).
CC   -!- FUNCTION: Acts as soluble receptor for class I MHC antigens. Binds both
CC       classical and non-classical HLA class I molecules but with reduced
CC       affinities compared to LILRB1 or LILRB2. Binds with high affinity to
CC       the surface of monocytes, leading to abolish LPS-induced TNF-alpha
CC       production by monocytes. {ECO:0000269|PubMed:21559424,
CC       ECO:0000269|PubMed:24085305}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8N6C8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N6C8-2; Sequence=VSP_045887;
CC       Name=3;
CC         IsoId=Q8N6C8-3; Sequence=VSP_045886;
CC   -!- TISSUE SPECIFICITY: Detected in B-cells, and at lower levels in natural
CC       killer (NK) cells. Detected in peripheral blood monocytes and lung.
CC       {ECO:0000269|PubMed:9278324, ECO:0000269|PubMed:9548455}.
CC   -!- PTM: N-glycosylation is required for ligand binding.
CC       {ECO:0000269|PubMed:24085305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U91926; AAB68666.1; -; mRNA.
DR   EMBL; U91927; AAB68667.1; -; mRNA.
DR   EMBL; AF025527; AAB87661.1; -; mRNA.
DR   EMBL; AF014924; AAC51886.1; -; mRNA.
DR   EMBL; AC008984; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010518; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC028208; AAH28208.1; -; mRNA.
DR   EMBL; AF482762; AAM18035.1; -; Genomic_DNA.
DR   EMBL; AF482763; AAM18036.1; -; Genomic_DNA.
DR   EMBL; AF482764; AAM18037.1; -; Genomic_DNA.
DR   EMBL; AF482765; AAM18038.1; -; Genomic_DNA.
DR   EMBL; AF482766; AAM18039.1; -; Genomic_DNA.
DR   EMBL; AF482767; AAM18040.1; -; Genomic_DNA.
DR   EMBL; AF482768; AAM18041.1; -; Genomic_DNA.
DR   EMBL; AF482769; AAM18042.1; -; Genomic_DNA.
DR   RefSeq; NP_001166125.1; NM_001172654.2. [Q8N6C8-2]
DR   RefSeq; NP_006856.3; NM_006865.4. [Q8N6C8-1]
DR   PDB; 3Q2C; X-ray; 2.50 A; A=24-120.
DR   PDBsum; 3Q2C; -.
DR   SMR; Q8N6C8; -.
DR   BioGRID; 116216; 7.
DR   IntAct; Q8N6C8; 5.
DR   GlyGen; Q8N6C8; 5 sites.
DR   iPTMnet; Q8N6C8; -.
DR   PhosphoSitePlus; Q8N6C8; -.
DR   BioMuta; LILRA3; -.
DR   DMDM; 92090611; -.
DR   jPOST; Q8N6C8; -.
DR   MassIVE; Q8N6C8; -.
DR   PaxDb; Q8N6C8; -.
DR   PeptideAtlas; Q8N6C8; -.
DR   PRIDE; Q8N6C8; -.
DR   ProteomicsDB; 72158; -. [Q8N6C8-1]
DR   DNASU; 11026; -.
DR   Ensembl; ENST00000612127; ENSP00000484119; ENSG00000278046. [Q8N6C8-1]
DR   Ensembl; ENST00000615652; ENSP00000482971; ENSG00000273884. [Q8N6C8-1]
DR   Ensembl; ENST00000617541; ENSP00000477708; ENSG00000275841. [Q8N6C8-2]
DR   Ensembl; ENST00000619638; ENSP00000481818; ENSG00000275841. [Q8N6C8-1]
DR   Ensembl; ENST00000620589; ENSP00000480386; ENSG00000276175. [Q8N6C8-1]
DR   GeneID; 11026; -.
DR   KEGG; hsa:11026; -.
DR   UCSC; uc032ini.2; human. [Q8N6C8-1]
DR   CTD; 11026; -.
DR   DisGeNET; 11026; -.
DR   GeneCards; LILRA3; -.
DR   HGNC; HGNC:6604; LILRA3.
DR   MIM; 604818; gene.
DR   neXtProt; NX_Q8N6C8; -.
DR   PharmGKB; PA30378; -.
DR   InParanoid; Q8N6C8; -.
DR   OMA; NAYLLTH; -.
DR   OrthoDB; 1000446at2759; -.
DR   PhylomeDB; Q8N6C8; -.
DR   TreeFam; TF336644; -.
DR   PathwayCommons; Q8N6C8; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   BioGRID-ORCS; 11026; 4 hits in 557 CRISPR screens.
DR   GeneWiki; LILRA3; -.
DR   GenomeRNAi; 11026; -.
DR   Pharos; Q8N6C8; Tbio.
DR   PRO; PR:Q8N6C8; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q8N6C8; protein.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0101003; C:ficolin-1-rich granule membrane; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0035579; C:specific granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   Gene3D; 2.60.40.10; -; 4.
DR   InterPro; IPR016332; A1B_glyco/leuk_Ig-like_rcpt.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   Pfam; PF13895; Ig_2; 2.
DR   PIRSF; PIRSF001979; Alpha_1B_glycoprot_prd; 1.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 3.
DR   SUPFAM; SSF48726; SSF48726; 4.
DR   PROSITE; PS50835; IG_LIKE; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Immunity;
KW   Immunoglobulin domain; Receptor; Reference proteome; Repeat; Secreted;
KW   Signal.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000269|PubMed:15340161"
FT   CHAIN           24..439
FT                   /note="Leukocyte immunoglobulin-like receptor subfamily A
FT                   member 3"
FT                   /id="PRO_0000014818"
FT   DOMAIN          27..108
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          119..224
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          226..315
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          326..415
FT                   /note="Ig-like C2-type 4"
FT   CARBOHYD        140
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24085305"
FT   CARBOHYD        281
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24085305"
FT   CARBOHYD        302
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24085305"
FT   CARBOHYD        341
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24085305"
FT   CARBOHYD        431
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:24085305"
FT   DISULFID        49..98
FT                   /evidence="ECO:0000269|PubMed:21559424,
FT                   ECO:0007744|PDB:3Q2C"
FT   DISULFID        145..197
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        157..167
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        246..297
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        346..397
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1
FT                   /note="M -> MHRGLIHPQSSAVGGDAM (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_045886"
FT   VAR_SEQ         158..221
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9079806"
FT                   /id="VSP_045887"
FT   VARIANT         3
FT                   /note="P -> S (in dbSNP:rs11574606)"
FT                   /evidence="ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:9278324, ECO:0000269|PubMed:9548455"
FT                   /id="VAR_016990"
FT   VARIANT         107
FT                   /note="L -> R (in dbSNP:rs6509862)"
FT                   /evidence="ECO:0000269|PubMed:12750859"
FT                   /id="VAR_016991"
FT   VARIANT         301
FT                   /note="Y -> H (in dbSNP:rs4473306)"
FT                   /evidence="ECO:0000269|PubMed:12750859"
FT                   /id="VAR_016992"
FT   CONFLICT        105
FT                   /note="A -> V (in Ref. 5; AAH28208)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        223
FT                   /note="S -> P (in Ref. 1; AAB68667)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        250
FT                   /note="A -> T (in Ref. 6; AAM18037)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        371
FT                   /note="S -> L (in Ref. 1; AAB68667)"
FT                   /evidence="ECO:0000305"
FT   STRAND          30..35
FT                   /evidence="ECO:0007744|PDB:3Q2C"
FT   STRAND          37..40
FT                   /evidence="ECO:0007744|PDB:3Q2C"
FT   STRAND          45..50
FT                   /evidence="ECO:0007744|PDB:3Q2C"
FT   STRAND          52..56
FT                   /evidence="ECO:0007744|PDB:3Q2C"
FT   STRAND          58..65
FT                   /evidence="ECO:0007744|PDB:3Q2C"
FT   HELIX           68..72
FT                   /evidence="ECO:0007744|PDB:3Q2C"
FT   HELIX           75..79
FT                   /evidence="ECO:0007744|PDB:3Q2C"
FT   STRAND          82..87
FT                   /evidence="ECO:0007744|PDB:3Q2C"
FT   HELIX           90..92
FT                   /evidence="ECO:0007744|PDB:3Q2C"
FT   STRAND          94..102
FT                   /evidence="ECO:0007744|PDB:3Q2C"
FT   TURN            103..105
FT                   /evidence="ECO:0007744|PDB:3Q2C"
FT   STRAND          106..108
FT                   /evidence="ECO:0007744|PDB:3Q2C"
FT   STRAND          114..119
FT                   /evidence="ECO:0007744|PDB:3Q2C"
SQ   SEQUENCE   439 AA;  47472 MW;  3932C6DA202ED5F5 CRC64;
     MTPILTVLIC LGLSLDPRTH VQAGPLPKPT LWAEPGSVIT QGSPVTLRCQ GSLETQEYHL
     YREKKTALWI TRIPQELVKK GQFPILSITW EHAGRYCCIY GSHTAGLSES SDPLELVVTG
     AYSKPTLSAL PSPVVTSGGN VTIQCDSQVA FDGFILCKEG EDEHPQCLNS HSHARGSSRA
     IFSVGPVSPS RRWSYRCYGY DSRAPYVWSL PSDLLGLLVP GVSKKPSLSV QPGPVVAPGE
     KLTFQCGSDA GYDRFVLYKE WGRDFLQRPG RQPQAGLSQA NFTLGPVSRS YGGQYTCSGA
     YNLSSEWSAP SDPLDILITG QIRARPFLSV RPGPTVASGE NVTLLCQSQG GMHTFLLTKE
     GAADSPLRLK SKRQSHKYQA EFPMSPVTSA HAGTYRCYGS LSSNPYLLTH PSDPLELVVS
     GAAETLSPPQ NKSDSKAGE
//
